| Product Code: ETC6191458 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Software as a Medical Device (SaMD) Market in Australia covers software intended for medical purposes without being part of a hardware medical device. This includes diagnostic algorithms, clinical decision support software, and health monitoring applications. Regulatory clarity from bodies like the Therapeutic Goods Administration (TGA) and rising acceptance of digital health solutions drive market expansion.
The SaMD market in Australia is rapidly evolving due to regulatory clarity and rising adoption of AI-powered diagnostic and monitoring tools. Emphasis on interoperability, data security, and real-world evidence generation is shaping market growth, alongside growing telehealth utilization.
The SaMD Market faces complex regulatory hurdles as medical device software must comply with both software and medical device regulations, causing long approval timelines. Ensuring cybersecurity and patient data privacy is critical but challenging. Rapid technology evolution demands frequent updates, complicating validation and risk management processes.
The SaMD market is emerging as a high-potential area due to regulatory acceptance and integration of software in healthcare diagnostics and therapeutics. Investment opportunities include developing AI-powered diagnostic tools, remote patient monitoring software, and clinical decision support systems. Collaborations with healthcare providers and regulatory bodies will be crucial to navigate compliance and accelerate product adoption.
The SaMD market is regulated by the TGA under medical device frameworks that classify software based on risk to patients. Government policies mandate rigorous clinical evaluation, quality management systems, and post-market vigilance for SaMD products. Additionally, policies encourage digital health innovation while ensuring patient safety and compliance with international standards like the IMDRF SaMD guidelines.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Software as a Medical Device (SaMD) Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Software as a Medical Device (SaMD) Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Software as a Medical Device (SaMD) Market - Industry Life Cycle |
3.4 Australia Software as a Medical Device (SaMD) Market - Porter's Five Forces |
3.5 Australia Software as a Medical Device (SaMD) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Software as a Medical Device (SaMD) Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Australia Software as a Medical Device (SaMD) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing adoption of digital healthcare solutions in Australia |
4.2.2 Rising prevalence of chronic diseases driving the demand for innovative medical technologies |
4.2.3 Government initiatives supporting the development and adoption of software as a medical device (SaMD) |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and compliance of SaMD products |
4.3.2 Data privacy and security concerns impacting the adoption of SaMD solutions |
4.3.3 Limited awareness among healthcare professionals about the benefits and functionalities of SaMD |
5 Australia Software as a Medical Device (SaMD) Market Trends |
6 Australia Software as a Medical Device (SaMD) Market, By Types |
6.1 Australia Software as a Medical Device (SaMD) Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Software as a Medical Device (SaMD) Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Software as a Medical Device (SaMD) Market Revenues & Volume, By Cloud-based, 2021- 2031F |
6.1.4 Australia Software as a Medical Device (SaMD) Market Revenues & Volume, By On Premise, 2021- 2031F |
6.2 Australia Software as a Medical Device (SaMD) Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Software as a Medical Device (SaMD) Market Revenues & Volume, By Screening and Diagnosis, 2021- 2031F |
6.2.3 Australia Software as a Medical Device (SaMD) Market Revenues & Volume, By Monitoring and Alerting, 2021- 2031F |
6.2.4 Australia Software as a Medical Device (SaMD) Market Revenues & Volume, By Chronic Disease Management, 2021- 2031F |
7 Australia Software as a Medical Device (SaMD) Market Import-Export Trade Statistics |
7.1 Australia Software as a Medical Device (SaMD) Market Export to Major Countries |
7.2 Australia Software as a Medical Device (SaMD) Market Imports from Major Countries |
8 Australia Software as a Medical Device (SaMD) Market Key Performance Indicators |
8.1 Percentage increase in the number of healthcare facilities using SaMD |
8.2 Average time taken for regulatory approval of new SaMD products |
8.3 Rate of integration of SaMD solutions with existing healthcare systems |
8.4 Number of reported cybersecurity incidents related to SaMD |
8.5 Rate of training sessions conducted for healthcare professionals on the use of SaMD |
9 Australia Software as a Medical Device (SaMD) Market - Opportunity Assessment |
9.1 Australia Software as a Medical Device (SaMD) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Software as a Medical Device (SaMD) Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Australia Software as a Medical Device (SaMD) Market - Competitive Landscape |
10.1 Australia Software as a Medical Device (SaMD) Market Revenue Share, By Companies, 2024 |
10.2 Australia Software as a Medical Device (SaMD) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here